None	of <RT_DOSE-START> 30 Gy <RT_DOSE-END> to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final <Boost-START> boost <Boost-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final <Boost-START> boost <Boost-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final <Boost-START> boost <Boost-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final <Boost-START> boost <Boost-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
None	of 30 Gy to point A given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions x 25 fractions , then a 5.4 Gy final <Boost-START> boost <Boost-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6
DOSE-BOOST	given in 5 fractions , starting week 4 of XRT 1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a <RT_DOSE-START> 5.4 Gy <RT_DOSE-END> final <Boost-START> boost <Boost-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice
None	1.8 Gy fractions x 28 fractions , for a total dose of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final <Boost-START> boost <Boost-END> , for a total dose of <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 (
None	of 50.4 Gy . The last 5.4 Gy of the 50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final <Boost-START> boost <Boost-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions
None	50.4 Gy is limited to the tumor bed . 1.8 Gy fractions x 25 fractions , then a 5.4 Gy final <Boost-START> boost <Boost-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then <RT_DOSE-START> 180 cGy <RT_DOSE-END> x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25
None	fractions x 25 fractions , then a 5.4 Gy final <Boost-START> boost <Boost-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> over 6 weeks in 1.5-Gy fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions
None	5.4 Gy final <Boost-START> boost <Boost-END> , for a total dose of 50.4 Gy , starting within 24 hours of start of chemotherapy 180 cGy x 22 with 3 cm margin to GTV then 180 cGy x 6 with 2 cm margin to GTV , total 50.4 Gy over 6 weeks <RT_DOSE-START> 1.5-Gy <RT_DOSE-END> fractions twice per day on days - 8 through - 5 ( total dose : 12 Gy ) 2 Gy x 25 fractions ( total of 50 Gy ) 2.0 Gy x 25 fractions , for a dose of 50 Gy with 150 cGy fractions given twice per day ( fractions
None	Tertiary planning treatment volume ( PTV3 ) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and <RT_DOSE-START> 50.4 Gy <RT_DOSE-END> , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Boost-START> boost <Boost-END> to
None	) included the area of the GTV adjacent to the vascular structures specifically the mesenteric and portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . <RT_DOSE-START> 4500 cGy <RT_DOSE-END> is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Boost-START> boost <Boost-END> to involved fields 58 to 66
None	portal vessels with a 0.5-cm margin . The prescription dose delivered to PTV3 was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by <RT_DOSE-START> 1080 cGy <RT_DOSE-END> to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Boost-START> boost <Boost-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting
None	was 54 Gy in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of <RT_DOSE-START> 5580 cGy <RT_DOSE-END> 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Boost-START> boost <Boost-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in
None	in 28 fractions . Synchronously , PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy <RT_DOSE-START> 36 Gy <RT_DOSE-END> in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Boost-START> boost <Boost-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions
None	, PTV1 and PTV2 received 45 and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of <RT_DOSE-START> 2.00 Gy <RT_DOSE-END> per fraction , with 4 Gy <Boost-START> boost <Boost-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ;
DOSE-BOOST	and 50.4 Gy , respectively . 4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with <RT_DOSE-START> 4 Gy <RT_DOSE-END> <Boost-START> boost <Boost-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total
None	4500 cGy is administered to the tumor volume plus a 3 cm margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Boost-START> boost <Boost-END> to involved fields 58 to <RT_DOSE-START> 58 to 66 Gy <RT_DOSE-END> , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors
None	margin , followed by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Boost-START> boost <Boost-END> to involved fields 58 to 66 Gy , given 5 times per week to <RT_DOSE-START> 50 Gy <RT_DOSE-END> in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2
None	by 1080 cGy to only the preradiation tumor volume , for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Boost-START> boost <Boost-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin
None	, for a total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Boost-START> boost <Boost-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 23.4 Gy <RT_DOSE-END> in 1.80-Gy fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given
None	total dose of 5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Boost-START> boost <Boost-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy <RT_DOSE-START> 1.80-Gy <RT_DOSE-END> fractions 45 Gy in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation
None	5580 cGy 36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Boost-START> boost <Boost-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions <RT_DOSE-START> 45 Gy <RT_DOSE-END> in 1.8 Gy fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of
None	36 Gy in 18 fractions of 2.00 Gy per fraction , with 4 Gy <Boost-START> boost <Boost-END> to involved fields 58 to 66 Gy , given 5 times per week to 50 Gy in 1.00-Gy fractions , starting on day 90 to 23.4 Gy in 1.80-Gy fractions 45 Gy in <RT_DOSE-START> 1.8 Gy <RT_DOSE-END> fractions to the initial tumor volume ; additional treatment up to a total of 55.8 Gy was administered to original bony tumors and the postinduction chemotherapy soft tissue volumes plus a 2 cm margin to 2400 cGy to 2400 cGy , given during consolidation total dose of 50.4 Gy
None	10 fractions over 12 to 14 days 28 Gy total given ( no details provided ) 72 Gy 800 cGy in 4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : <RT_DOSE-START> 1.8 to 2.0 Gy <RT_DOSE-END> once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 40 Gy at 1.80 Gy
None	4 fractions ( days not specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of <RT_DOSE-START> 46 to 50.4 Gy <RT_DOSE-END> 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day
None	specified ) 40.8 Gy ; total induction dose to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy <RT_DOSE-START> 1.00-Gy <RT_DOSE-END> fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days
None	to regional lymph nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to <RT_DOSE-START> 30 Gy <RT_DOSE-END> in 1.8-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to
None	nodes given before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in <RT_DOSE-START> 1.8-Gy <RT_DOSE-END> fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 ,
DOSE-BOOST	before or after surgery at physician discretion : 1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus <RT_DOSE-START> 10 Gy <RT_DOSE-END> <Boost-START> boost <Boost-END> to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6
None	1.8 to 2.0 Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed <RT_DOSE-START> 40 Gy <RT_DOSE-END> at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose
None	Gy once per day Monday through Friday for a total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 40 Gy at <RT_DOSE-START> 1.80 Gy <RT_DOSE-END> / day to the involved field 59 to 60 Gy in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy
None	total of 23 to 28 fractions , for a total dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to <RT_DOSE-START> 59 to 60 Gy <RT_DOSE-END> in 30 to 33 fractions 1.5 Gy fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times
None	dose of 46 to 50.4 Gy 1.00-Gy fractions , starting on day 90 to 30 Gy in 1.8-Gy fractions plus 10 Gy <Boost-START> boost <Boost-END> to the tumor bed 40 Gy at 1.80 Gy / day to the involved field 59 to 60 Gy in 30 to 33 fractions <RT_DOSE-START> 1.5 Gy <RT_DOSE-END> fractions given twice per day on days 1 to 5 , 8 to 12 , 15 to 19 , with at least 6 hours between fractions , for a total dose of 45 Gy 1.2 Gy fractions given twice per day , 5 times per week ( total dose : 75 Gy
